Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.50 |
| ▸ | LPL | P06858 | 13/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | F11 | P03951 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12781865 | 0.97 | LIPG (0.56) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL70387 | 0.93 | LIPG (0.59) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL69358 | 0.93 | LIPG (0.47) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL429991 | 0.93 | LIPG (0.64) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL431646 | 0.93 | LIPG (0.51) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL430244 | 0.93 | LIPG (0.51) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL19612784 | 0.90 | LIPG (0.46) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL16435209 | 0.90 | LIPG (0.44) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL69840 | 0.89 | LIPG (0.50) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL12056858 | 0.89 | LIPG (0.70) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481175-B2 | Oligofluorene compound and organic EL element using same | CANON KABUSHIKI KAISHA (JP) | 2013-07-09 | — | — | US | disclosed |
| US-8481175-B2 | Oligofluorene compound and organic EL element using same | CANON KABUSHIKI KAISHA (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20120168739-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120168739-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-05 | — | — | US | disclosed |
| US-8158835-B2 | Fluorene compound and organic electroluminescence device | CANON KABUSHIKI KAISHA (JP) | 2012-04-17 | — | — | US | disclosed |
| US-8158835-B2 | Fluorene compound and organic electroluminescence device | CANON KABUSHIKI KAISHA (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090115323-A1 | OLIGOFLUORENE COMPOUND AND ORGANIC EL ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20090115323-A1 | OLIGOFLUORENE COMPOUND AND ORGANIC EL ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168739-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AFF1, LEF1, AFF2 | LIPG 2072/4885LPL 1917/4885CA1 2732/4885 |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AFF1, LEF1, AFF2 | LIPG 2072/4885LPL 1917/4885CA1 2732/4885 |
| US-20090115323-A1 | OLIGOFLUORENE COMPOUND AND ORGANIC EL ELEMENT USING SAME | ELP1, LEF1, ELAVL1 | LIPG 2759/4885LPL 2134/4885CA1 1213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.